FDA Inspection 1019977 — Seattle Reproductive Medicine, Inc., P.S.

Seattle Reproductive Medicine, Inc., P.S. — FEI 3005033540

The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on July 11, 2017 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 11, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Seattle, WA (United States)